THE DEFINITIVE GUIDE TO API PHARMACEUTICAL

“The current problem has exposed some structural weaknesses within the EU’s medicines offer chain plus a superior dependence on non-EU international locations for active pharmaceutical ingredients,” Kyriakides stated. She recommended that supply chain troubles be tackled within an EU pharmaceutical system predicted to be released by the end w